Efficacy and safety of APT198K for the treatment of infantile colic: A pilot study

Journal of Comparative Effectiveness Research

Volumn 6, Issue 2, 2017, Pages 137-144

  Vandenplas, Yvan ^a   Bacarea, Anca ^b   Marusteri, Marius ^b   Bacarea, Vlad ^b   Constantin, Mariana ^c   Manolache, Mihai ^d  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c Family Medicine   (Romania)

^d CEBIS International Ltd   (Romania)

Author keywords

APT198K; Bifidobacterium brevis; infantile colic; lactase; Lactobacillus reuteri; xyloglucan

Indexed keywords

APT 198K; GLUCAN; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; UNCLASSIFIED DRUG; APT198K; PROBIOTIC AGENT; XYLAN; XYLOGLUCAN;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFANT; INFANTILE COLIC; LIKERT SCALE; MALE; MULTICENTER STUDY; NEWBORN; OPEN STUDY; PILOT STUDY; POPULATION RESEARCH; RANDOMIZED CONTROLLED TRIAL; ROMANIA; TREATMENT DURATION; ABDOMINAL WALL MUSCULATURE; BIFIDOBACTERIUM BREVE; BODY POSITION; CLINICAL TRIAL; COLIC; COMPARATIVE STUDY; CRYING; DRUG COMBINATION; DRUG EFFECTS; FLATULENCE; FLUSHING; LACTOBACILLUS REUTERI; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ABDOMINAL MUSCLES; ADMINISTRATION, ORAL; BIFIDOBACTERIUM BREVE; COLIC; CRYING; DRUG COMBINATIONS; FEMALE; FLATULENCE; FLUSHING; GLUCANS; HUMANS; INFANT; INFANT, NEWBORN; LACTOBACILLUS REUTERI; MALE; PILOT PROJECTS; POSTURE; PROBIOTICS; TREATMENT OUTCOME; XYLANS;

EID: 85011579224     PISSN: 20426305     EISSN: 20426313     Source Type: Journal    
DOI: 10.2217/cer-2016-0059     Document Type: Article

References (33)

1. Vandenplas Y, Abkari A, Bellaiche M et al. Prevalence and health outcomes of functional gastrointestinal symptoms in infants from birth to 12 months of age. J. Pediatr. Gastroenterol. Nutr. 61(5), 531-537 (2015).
2. Bellaiche M, Levy M, Jung C. Treatments for infant colic. J. Pediatr. Gastroenterol. Nutr. 57(Suppl 1), S27-S30 (2013).
3. Benninga MA, Nurko S, Faure C et al. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology 150, 1443-1455 (2016).
4. Roberts DM, Ostapchuk M, O'Brien JG. Infantile colic. Am. Fam. Physician 70(4), 735-740 (2004).
5. Savino F, Ceratto S, De Marco A, di Montezemolo LC. Looking for new treatments of infantile colic. Ital. J. Pediatr. 40, 53 (2014).
6. Harb T, Matsuyama M, David M, Hill R. Infant colic-what works: A systematic review of interventions for breastfedinfants. J. Pediatr. Gastroenterol. Nutr. 62(5), 668-686 (2016).
7. Caffarelli C, Santamaria F, Cesari S et al. Advances in pediatrics in 2014: current practices and challenges in allergy, gastroenterology, infectious diseases, neonatology, nutrition, oncology and respiratory tract illnesses. Ital. J. Pediatr. 41, 84 (2015).
8. Pärtty A, Kalliomäki M, Endo A, Salminen S, Isolauri E. Compositional development of Bifidobacterium and Lactobacillus microbiota is linked with crying and fussing in early infancy. PLoS ONE 7(3), e32495 (2012).
9. Savino F, Cordisco L, Tarasco V, Calabrese R, Palumeri E, Matteuzzi D. Molecular identification of coliform bacteria from colicky breastfed infants. Acta Paediatr. 98(10), 1582-1588 (2009).
10. Xu M, Wang J, Wang N, Sun F, Wang L, Liu XH. The efficacy and safety of the probiotic bacterium Lactobacillus reuteri DSM 17938 for infantile colic: A meta-analysis of randomized controlled trials. PLoS ONE 10(10), e0141445 (2015).
11. Kataria J, Li N, Wynn JL, Neu J. Probiotic microbes: do they need to be alive to be beneficial? Nutr. Rev. 67(9), 546-550 (2009).
12. Adams CA. The probiotic paradox: live and dead cells are biological response modifiers. Nutr. Res. Rev. 23(1), 37-46 (2010).
13. Kanabar D, Randhawa M, Clayton P. Improvement of symptoms in infant colic following reduction of lactose load with lactase. J. Hum. Nutr. Diet 14(5), 359-363 (2001).
14. Miller JJ, McVeagh P, Fleet GH, Petocz P, Brand JC. Breath hydrogen excretion in infants with colic. Arch. Dis. Child. 64(5), 725-729 (1989).
15. Wessel MA, Cobb JC, Jackson EB, Harris GS, Detwiler AC. Paroxysmal fussing in infancy, sometimes called colic. Pediatrics 14(5), 421-435 (1954).
16. Cohen-Silver J, Ratnapalan S. Management of infantile colic: A review. Clin. Pediatr. (Phila. ) 48(1), 14-17 (2009).
17. Radesky JS, Zuckerman B, Silverstein M et al. Inconsolable infant crying and maternal postpartum depressive symptoms. Pediatrics 131(6), e1857-e1864 (2013).
18. Abaci FB, Gökçe S, Tuygun N, Karacan CD, Oner O. Psychosocial status and quality of life in mothers of infants with colic. Turk. J. Pediatr. 55(4), 391-395 (2013).
19. Critch J. Infantile colic: is there a role for dietary interventions? Paediatr. Child Health 16(1), 47-49 (2011).
20. de Weerth C, Fuentes S, Puylaert P, de Vos WM. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics 131(2), e550-e558 (2013).
21. Savino F, Bailo E, Oggero R et al. Bacterial counts of intestinal Lactobacillus species in infants with colic. Pediatr. Allergy Immunol. 16(1), 72-75 (2005).
22. Rhoads JM, Fatheree NY, Norori J et al. Altered fecal microflora and increased fecal calprotectin in infants with colic. J. Pediatr. 155(6), 823-828. e1 (2009).
23. Lehtonen L, Korvenranta H, Eerola E. Intestinal microflora in colicky and noncolicky infants: bacterial cultures and gasliquid chromatography. J. Pediatr. Gastroenterol. Nutr. 19(3), 310-314 (1994).
24. Simone M, Gozzoli C, Quartieri A et al. The probiotic Bifidobacterium breve B632 inhibited the growth of Enterobacteriaceae within colicky infant microbiota cultures. Biomed. Res. Int. 2014, 301053 (2014).
25. Savino F, Cordisco L, Tarasco V et al. Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infants. BMC Microbiol. 11, 157 (2011).
26. Chau K, Lau E, Greenberg S et al. Probiotics for infantile colic: A randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. J. Pediatr. 166(1), 74-78 (2015).
27. Sung V, Hiscock H, Tang ML et al. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ 348, g2107 (2014).
28. Bueno L, Theodorou V, Sekkal S. Xyloglucan: A new agent to protect the intestinal mucosa and to prevent bacteriallymediated alteration of tight junction permeability [Abstract P1675]. Presented at: United European Gastroenterology Week. Vienna, Austria, 18-22 October 2014.
29. Gnessi L, Bacarea V, Marusteri M, Picqué N. Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial. BMC Gastroenterol. 15(1), 153 (2015)
30. Ståhlberg MR, Savilahti E. Infantile colic and feeding. Arch. Dis. Child. 61(12), 1232-1233 (1986).
31. Miller JJ, McVeagh P, Fleet GH, Petocz P, Brand JC. Effect of yeast lactase enzyme on "colic" in infants fed human milk. J. Pediatr. 117(2 Pt 1), 261-263 (1990).
32. Kearney PJ, Malone AJ, Hayes T, Cole M, Hyland M. A trial of lactase in the management of infant colic. J. Hum. Nutr. Dietet. 11(4), 281-285 (1998).
33. National Institute for Health and Care Excellence (NICE). Clinical knowledge summaries: colic-infantile (November 2014). http://cks. nice. org. uk/colic-infantile